The effects of valsartan on scar maturation in an experimental rabbit ear wound model

References

• Kryger ZB, Sisco M, Roy NK, et al. Temporal expression of the transforming growth factor-beta pathway in the rabbit ear model of wound healing and scarring. J Am Coll Surg. 2007;205:78–88.
   PubMed Web of Science ®Google Scholar
• Morihara K, Takai S, Takenaka H, et al. Cutaneous tissue angiotensin-converting enzyme may participate in pathologic scar formation in human skin. J Am Acad Dermatol. 2006;54:251–257.
   PubMed Web of Science ®Google Scholar
• Zhang GY, Li X, Yi CG, et al. Angiotensin II activates connective tissue growth factor and induces extracellular matrix changes involving Smad/activation and p38 mitogen-activated protein kinase signalling pathways in human dermal fibroblasts. Exp Dermatol. 2009;18:947–953.
   PubMed Web of Science ®Google Scholar
• Steckelings UM, Henz BM, Wiehstutz S, et al. Differential expression of angiotensin receptors in human cutaneous wound healing. Br J Dermatol. 2005;153:887–893.
   PubMed Web of Science ®Google Scholar
• Liu HW, Cheng B, Yu WL, et al. Angiotensin II regulates phosphoinositide 3 kinase/Akt cascade via a negative crosstalk between AT1 and AT2 receptors in skin fibroblasts of human hypertrophic scars. Life Sci. 2006;79:475–483.
   PubMed Web of Science ®Google Scholar
• Uzun H, Bitik O, Hekimoğlu R, et al. Angiotensin-converting enzyme inhibitor enalapril reduces formation of hypertrophic scars in a rabbit ear wounding model. Plast Reconstr Surg. 2013;132:361e–371e.
   PubMed Web of Science ®Google Scholar
• Morris DE, Wu L, Zhao LL, et al. Acute and chronic animal models for excessive dermal scarring: quantitative studies. Plast Reconstr Surg. 1997;100:674–681.
   PubMed Web of Science ®Google Scholar
• Saulis AS, Mogford JH, Mustoe TA. Effect of mederma on hypertrophic scarring in the rabbit ear model. Plastic Reconstr Surg. 2002;110:177–183.
   PubMed Web of Science ®Google Scholar
• Wang H-j, Gao W-c, Ma S-l. Effect of Abnormal Savda Munziq on hypertrophic scar formation in a rabbit ear model. Chin J Integr Med. 2015;21:537–541.
   PubMed Web of Science ®Google Scholar
• Atiyeh BS. Nonsurgical management of hypertrophic scars: evidence-based therapies, standard practices, and emerging methods. Aesthetic Plast Surg. 2007;31:468–492.
   PubMed Web of Science ®Google Scholar
• Rabello FB, Souza CD, Farina Jr JA. Update on hypertrophic scar treatment. Clinics (Sao Paulo). 2014;69:565–573.
   PubMed Web of Science ®Google Scholar
• Anzarut A, Olson J, Singh P, et al. The effectiveness of pressure garment therapy for the prevention of abnormal scarring after burn injury: a meta-analysis. J Plast Reconstr Aesthet Surg. 2009;62:77–84.
   PubMed Web of Science ®Google Scholar
• Jalali M, Bayat A. Current use of steroids in management of abnormal raised skin scars. Surgeon. 2007;5:175–180.
   PubMed Web of Science ®Google Scholar
• Naeini FF, Najafian J, Ahmadpour K. Bleomycin tattooing as a promising therapeutic modality in large keloids and hypertrophic scars. Dermatol Surg. 2006;32:1023–1030.
   PubMed Web of Science ®Google Scholar
• Leclère FM, Mordon SR. Twenty-five years of active laser prevention of scars: what have we learned? J Cosmet Laser Ther. 2010;12:227–234.
   PubMed Web of Science ®Google Scholar
• O'Brien L, Jones DJ. Silicone gel sheeting for preventing and treating hypertrophic and keloid scars. Cochrane Database Syst Rev. 2013;CD003826.
   PubMed Web of Science ®Google Scholar
• Shih R, Waltzman J, Evans GRD, Plastic Surgery Educational Foundation Technology Assessment Committee. Review of over-the-counter topical scar treatment products. Plast Reconstr Surg. 2007;119:1091–1095.
   PubMed Web of Science ®Google Scholar
• Shin JU, Park J, Lee JH, et al. Extramarginal excision is preferable for hypertrophic scars. Int J Dermatol. 2014;53:1138–1144.
   PubMed Web of Science ®Google Scholar
• Huang D, Shen KH, Wang HG. Pressure therapy upregulates matrix metalloproteinase expression and downregulates collagen expression in hypertrophic scar tissue. Chin Med J (Engl). 2013;126:3321–3324.
   PubMed Web of Science ®Google Scholar
• Lee JYY, Yang CC, Chao SC, et al. Histopathological differential diagnosis of keloid and hypertrophic scar. Am J Dermatopathol. 2004;26:379–384.
   PubMed Web of Science ®Google Scholar
• Rodgers K, Abiko M, Girgis W, et al. Acceleration of dermal tissue repair by angiotensin II. Wound Repair Regen. 1997;5:175–183.
   PubMedGoogle Scholar
• Friedman DW, Boyd CD, Mackenzie JW, et al. Regulation of collagen gene expression in keloids and hypertrophic scars. J Surg Res. 1993;55:214–222.
   PubMed Web of Science ®Google Scholar
• Zhang K, Garner W, Cohen L, et al. Increased types I and III collagen and transforming growth factor-beta 1 mRNA and protein in hypertrophic burn scar. J Invest Dermatol. 1995;104:750–754.
   PubMed Web of Science ®Google Scholar
• Gauglitz GG, Korting HC, Pavicic T, et al. Hypertrophic scarring and keloids: pathomechanisms and current and emerging treatment strategies. Mol Med. 2011;17:113–125.
   PubMed Web of Science ®Google Scholar
• Gentile P, Scioli MG, Bielli A, et al. Comparing different nanofat procedures on scars: role of the stromal vascular fraction and its clinical implications. Regen Med. 2017;12:939–952.
   PubMed Web of Science ®Google Scholar
• Gentile P, De Angelis B, Pasin M, et al. Adipose-derived stromal vascular fraction cells and platelet-rich plasma: basic and clinical evaluation for cell-based therapies in patients with scars on the face. J Craniofac Surg. 2014;25:267–272.
   PubMed Web of Science ®Google Scholar
• Cervelli V, Bocchini I, Di Pasquali C, et al. P.R.L. platelet rich lipotransfert: our experience and current state of art in the combined use of fat and PRP. Biomed Res Int. 2013;2013:434191.
   PubMed Web of Science ®Google Scholar
• Cervelli V, Gentile P. Use of cell fat mixed with platelet gel in progressive hemifacial atrophy. Aesthetic Plast Surg. 2009;33:22–27.
   PubMed Web of Science ®Google Scholar